Treatment with the chimeric anti-IL-2Rα basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1007-1008

  Boelaars van Haperen, M J A M ^a   Baan, C C ^a   Van Riemsdijk, I C ^a   Ijzermans, J N M ^a   Weimar, W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; MEMBRANE PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; KIDNEY ALLOGRAFT REJECTION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-15; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PREDNISOLONE; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0035081013     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02306-X     Document Type: Conference Paper

References (7)

1. Lin J-X, Leonard WJ: Cytokine Growth Factor Rev 8:313, 1997
2. Berard JL, Velez RL, Freeman RB, et al: Pharmacotherapy 19:1127, 1999
3. Kahan BD, Rajagopalan PR, Hall M: Transplantation 67:276, 1999
4. Vincenti F, Monaco A, Grinyo J, et al: Transplantation 67:5152, 1999
5. Ransohoff RM: N Engl J Med 338:616, 1998
6. Tkaczuk J, Milford EL, Carpenter CB, et al: Transplantation 69:S397, 2000
7. Baan CC, van Gelder T, Balk AHMM, et al: Transplantation 69:331, 2000